Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.75. Bausch Health Companies Inc.
Stay updated with breaking news from Thomas Appio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.75. Bausch Health Companies Inc.
Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript May 2, 2024 Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.75. Bausch Health Companies Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […]
Xifaxin 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea in adults.
Bausch Health filed a patent lawsuit against Amneal Pharmaceuticals over Xifaxan.
Bausch Health Companies Inc. beats earnings expectations. Reported EPS is $1.15, expectations were $1.01.